Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00209_DB00761_nanopub.RA7BIwkqyQ1kCZPqb_EzRlYQZSXKvbdQAHVKRBw2DISEk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00209_DB00761 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00209_DB00761 label "DDI between Trospium and Potassium Chloride - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Trospium, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations. [drugbank_resource:DB00209_DB00761]" assertion.
- drugbank_resource:DB00209_DB00761 identifier "drugbank_resource:DB00209_DB00761" assertion.
- drugbank_resource:DB00209_DB00761 title "DDI between Trospium and Potassium Chloride - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Trospium, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations." assertion.
- drugbank:DB00761 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00209_DB00761 assertion.
- drugbank:DB00209 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00209_DB00761 assertion.